Vildagliptin for type 2 diabetes: No suitable data for combination with sulfonylurea
Monday, March 9, 2015 - 10:50
in Health & Medicine
New study data, on the basis of which the drug manufacturer applied for a new dossier assessment, were found by reviewers to be unsuitable: they not only compared two drugs, but also two therapeutic strategies.